Effects of Ginkgo biloba leaf extract and diphyridamole injection on concentration of plasma oxidized low density liporotein in patients with acute brain infarction
Yifeng Du
Abstract
Yifeng Du
Abstract
AIM:To observe the effects of Ginkgo biloba leaf extract and diphyridamole injection on the levels of plasma oxidized low density liporotein (OX-LDL), superoxide dismutase (SOD), and malondialdehyde (MDA) in patients with acute cerebral infarction. METHODS: Seventy-two patients with acute brain infarction were divided into treatment group (treated with Ginkgo biloba leaf extract and diphyridamole injection, 20 mL, iv, gtt, qd, n = 36) and control group (treated with Danxiang Guanxin injection, 20 mL, iv, gtt, qd, n = 36). All the patients were treated for 14 d. The levels of plasma OX-LDL, SOD, and MDA were tested before and after treatment. RESULTS; In treatment group the levels of plasma OX-LDL, SOD, MDA before treatment were (0.69±s 0.20) mg·L-1, (80±6) kU·L-1, (6.4±1.3)μmoL·L-1, and those after treatment were (0.54±0.23) mg·L-1, (107±9) kU·L-1, (4.1±1.0)μmoL·L-1, resulting with a great difference between them (P 0.01). No significant statistical differences were found in the above mentioned assessment indexes in control group before and aftert treatment (P 0.05) . No remarkable adverse reactions occurred during this study in both groups. CONCLUSION: Ginkgo biloba leaf extract and diphyridamole injection can effectively clear out the free radicals and decrease the level of the plasma OX-LDL.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
AIM:To observe the effects of Ginkgo biloba leaf extract and diphyridamole injection on the levels of plasma oxidized low density liporotein (OX-LDL), superoxide dismutase (SOD), and malondialdehyde (MDA) in patients with acute cerebral infarction. METHODS: Seventy-two patients with acute brain infarction were divided into treatment group (treated with Ginkgo biloba leaf extract and diphyridamole injection, 20 mL, iv, gtt, qd, n = 36) and control group (treated with Danxiang Guanxin injection, 20 mL, iv, gtt, qd, n = 36). All the patients were treated for 14 d. The levels of plasma OX-LDL, SOD, and MDA were tested before and after treatment. RESULTS; In treatment group the levels of plasma OX-LDL, SOD, MDA before treatment were (0.69±s 0.20) mg·L-1, (80±6) kU·L-1, (6.4±1.3)μmoL·L-1, and those after treatment were (0.54±0.23) mg·L-1, (107±9) kU·L-1, (4.1±1.0)μmoL·L-1, resulting with a great difference between them (P 0.01). No significant statistical differences were found in the above mentioned assessment indexes in control group before and aftert treatment (P 0.05) . No remarkable adverse reactions occurred during this study in both groups. CONCLUSION: Ginkgo biloba leaf extract and diphyridamole injection can effectively clear out the free radicals and decrease the level of the plasma OX-LDL.
Key concepts: Ginkgo biloba, Malondialdehyde, Superoxide dismutase, Ginkgoales, Chemistry, Ginkgo, Cerebral infarction, Pharmacology